Haleon Plc - ADR (HLN) | Stock Overview & Key Data
Haleon Plc - ADR Performance Comparison
Stock Range
Today's Range
Low: $8.84
High: $8.92
on October 2, 2025
52 Week Range
Low: $8.71
High: $11.42
on September 25, 2025
on June 2, 2025
All-Time High: $11.42 on June 2, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$41.7B
EPS
0.45
P/E Ratio (TTM)
19.93
Forward P/E
21.36
P/B Ratio
5.08
PEG Ratio
21.36
Div. Yield
1.63%
ROE
9.38%
Beta
0.238
Debt to Equity
53.41
Financial Highlights
Profitability
Gross Margin
55.38%
Operating Margin
22.21%
Profit Margin
13.81%
Returns and Earnings
Return on Assets (TTM)
4.61%
Return on Equity (TTM)
9.38%
EBITDA
$3.0B
Net Income (TTM)
$2.0B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$1.21
Quarterly Revenue Growth (YoY)
-1.30%
Quarterly Earnings Growth (YoY)
33.00%
Dividend Information
Last 12-Month Dividend
$0.17
Current Dividend Yield
1.63%
3-Year Average Dividend Yield
0.91%
3-Year Average Annual Dividend
$0.11
3-Year Total Dividends
$0.34
Ex-Dividend Date
April 25, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Haleon Plc - ADR HLN | 41.72B Large-cap | 1.83% | -9.02% | -13.45% | -12.60% | -5.93% | -14.37% | 45.81% | 19.84% |
| United Therapeutics UTHR | 19.33B Large-cap | 4.24% | 9.54% | 50.21% | 42.01% | 23.10% | 24.59% | 114.46% | 326.34% |
| Intra-Cellular ITCI | 14.05B Large-cap | 0.14% | 0.45% | 56.54% | 82.52% | 56.54% | 92.68% | 104.13% | 700.67% |
| Neurocrine NBIX | 13.75B Large-cap | -2.95% | -3.65% | 5.67% | 26.25% | -0.81% | 19.95% | 26.32% | 30.95% |
| Viatris VTRS | 11.77B Large-cap | 6.53% | -4.26% | 8.24% | 16.74% | -18.60% | -12.77% | 15.68% | -35.36% |
| Zoetis ZTS | 63.73B | -1.63% | -7.29% | -7.89% | -11.87% | -11.75% | -26.34% | -3.23% | -12.26% |
Ownership & Short Interest
Insider Ownership
0.02%
Institutional Ownership
12.90%
Shares Short
16M
Short Ratio
1.93
Short % of Shares Outstanding
0.35%
Average 10-Day Volume
10M
Average 90-Day Volume
9M
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is HLN's 52-week high and low?
- In the last 52 weeks, Haleon Plc - ADR reached a high of $11.42 (on June 2, 2025) and a low of $8.71 (on September 25, 2025).
- What is the market cap and P/E ratio for HLN?
- Curious about Haleon Plc - ADR's size and valuation? Its market capitalization stands at 41.72B. When it comes to valuation, the P/E ratio (trailing twelve months) is 19.93, and the forward P/E (looking ahead) is 21.36.
- Does HLN pay dividends? If so, what's the yield?
- Yes, Haleon Plc - ADR is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.63%, and the company has paid an average of $0.11 per share annually over the past 3 years.
- Who are Haleon Plc - ADR's main competitors or similar companies to consider before investing?
When looking at Haleon Plc - ADR, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return United Therapeutics
UTHR19.33B Healthcare Drug Manufacturers - Specialty & Generic 24.59% 114.46% Intra-Cellular
ITCI14.05B Healthcare Drug Manufacturers - Specialty & Generic 92.68% 104.13% Neurocrine
NBIX13.75B Healthcare Drug Manufacturers - Specialty & Generic 19.95% 26.32% Viatris
VTRS11.77B Healthcare Drug Manufacturers - Specialty & Generic -12.77% 15.68% Zoetis
ZTS63.73B Healthcare Drug Manufacturers - Specialty & Generic -26.34% -3.23% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Haleon Plc - ADR? (e.g., ROE, Debt/Equity)
- To get a sense of Haleon Plc - ADR's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 9.38%, the Debt to Equity ratio from the most recent quarter is 53.41, and its Gross Profit Margin stands at 55.38%.
- What is the recent revenue and earnings growth for HLN?
- Looking at Haleon Plc - ADR's growth, its revenue over the trailing twelve months (TTM) was $15B. Compared to the same quarter last year (YoY), quarterly revenue grew by -1.30%, and quarterly earnings saw a YoY growth of 33.00%.
- How much of HLN stock is held by insiders and institutions?
- Wondering who owns Haleon Plc - ADR stock? Company insiders (like executives and directors) hold about 0.02% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 12.90%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.